Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Phase I study of weekly nab-paclitaxel plus carboplatin and concurrent thoracic radiotherapy in elderly patients with unresectable locally advanced non-small cell lung cancer.
Invest New Drugs. 2022 Feb;40(1):106-114. doi: 10.1007/s10637-021-01155-w. Epub 2021 Sep 8.
Invest New Drugs. 2022.
PMID: 34495421
Clinical Trial.
Osimertinib for patients with poor performance status and EGFR T790M mutation-positive advanced non-small cell lung cancer: a phase II clinical trial.
Nakashima K, Ozawa Y, Daga H, Imai H, Tamiya M, Tokito T, Kawamura T, Akamatsu H, Tsuboguchi Y, Takahashi T, Yamamoto N, Mori K, Murakami H.
Nakashima K, et al. Among authors: tsuboguchi y.
Invest New Drugs. 2020 Dec;38(6):1854-1861. doi: 10.1007/s10637-020-00943-0. Epub 2020 May 18.
Invest New Drugs. 2020.
PMID: 32424780
Clinical Trial.
Item in Clipboard
Plasma screening for the T790M mutation of EGFR and phase 2 study of osimertinib efficacy in plasma T790M-positive non-small cell lung cancer: West Japan Oncology Group 8815L/LPS study.
Takahama T, Azuma K, Shimokawa M, Takeda M, Ishii H, Kato T, Saito H, Daga H, Tsuboguchi Y, Okamoto I, Otsubo K, Akamatsu H, Teraoka S, Takahashi T, Ono A, Ohira T, Yokoyama T, Sakai K, Yamamoto N, Nishio K, Nakagawa K.
Takahama T, et al. Among authors: tsuboguchi y.
Cancer. 2020 Jan 1;126(9):1940-1948. doi: 10.1002/cncr.32749. Epub 2020 Feb 5.
Cancer. 2020.
PMID: 32022929
Free article.
Clinical Trial.
Item in Clipboard
Clinical benefit of treatment after trastuzumab emtansine for HER2-positive metastatic breast cancer: a real-world multi-centre cohort study in Japan (WJOG12519B).
Yokoe T, Kurozumi S, Nozawa K, Ozaki Y, Maeda T, Yazaki S, Onishi M, Fujimoto A, Nakayama S, Tsuboguchi Y, Iwasa T, Sakai H, Ogata M, Terada M, Nishimura M, Onoe T, Masuda J, Kurikawa M, Isaka H, Hagio K, Shimomura A, Okumura Y, Futamura M, Shimokawa M, Takano T.
Yokoe T, et al. Among authors: tsuboguchi y.
Breast Cancer. 2021 May;28(3):581-591. doi: 10.1007/s12282-020-01192-y. Epub 2021 Jan 2.
Breast Cancer. 2021.
PMID: 33389616
Free PMC article.
Item in Clipboard
Sentinel node biopsy for axillary management after neoadjuvant therapy for breast cancer: a single-center retrospective analysis with long follow-up.
Ogawa Y, Ikeda K, Watanabe C, Kamei Y, Tokunaga S, Tsuboguchi Y, Inoue T, Fukushima H, Ichiki M.
Ogawa Y, et al. Among authors: tsuboguchi y.
Surg Today. 2018 Jan;48(1):87-94. doi: 10.1007/s00595-017-1558-y. Epub 2017 Jun 24.
Surg Today. 2018.
PMID: 28647776
Item in Clipboard
Super-elderly patient-specific perioperative complications in breast cancer surgery.
Ogawa Y, Ikeda K, Watanabe C, Kamei Y, Goto W, Shiraishi C, Tokunaga S, Tsuboguchi Y.
Ogawa Y, et al. Among authors: tsuboguchi y.
Surg Today. 2019 Oct;49(10):843-849. doi: 10.1007/s00595-019-01812-x. Epub 2019 Apr 22.
Surg Today. 2019.
PMID: 31011870
Item in Clipboard
mDia1 targets v-Src to the cell periphery and facilitates cell transformation, tumorigenesis, and invasion.
Tanji M, Ishizaki T, Ebrahimi S, Tsuboguchi Y, Sukezane T, Akagi T, Frame MC, Hashimoto N, Miyamoto S, Narumiya S.
Tanji M, et al. Among authors: tsuboguchi y.
Mol Cell Biol. 2010 Oct;30(19):4604-15. doi: 10.1128/MCB.00197-10. Epub 2010 Aug 2.
Mol Cell Biol. 2010.
PMID: 20679479
Free PMC article.
Item in Clipboard
Cite
Cite